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ABSTRACT 
All over the world currently there are billions of people who use tobacco regularly that’s why now these days the tobacco is one of 
the most widely used drug. Many of scientific evidences reveal that tobacco is dangerous to human health. Tobacco contains 
plethora of harmful chemical substances, out of which many of them are carcinogens. Smoking is responsible for 90% of all lung 
cancer and mouth cancer, 75% of chronic bronchitis and emphysema and 25 % of ischemic heart disease cases so tobacco is one of 
the leading preventable causes of deaths. In consideration of all these factors this review discusses various aspects of these 
electronic cigarettes like their structural components, working mechanism and their role in smoking cessation. E-cigarettes now 
gained a lot of popularity. This review also helps to aware health care professionals along with general population about the safety, 
myths, future challenges and about all pros and cons of using E-cigarettes. 
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INTRODUCTION 
The fact that existence of tobacco in human life is from 
many last centuries which cannot be denied and became 
possible due to the addiction causing property of tobacco. 
Various conventional forms of tobacco like cigarettes, 
cigar and chewable tobacco as dip or snuff are delivering 
nicotine and many other harmful chemicals into the 
human body. Heavy intake of tobacco causes 
accumulative health problems that can lead to death no 
matter how tobacco was taken 1. Chemical present in the 
smoke of tobacco are responsible of causing lung, throat, 
mouth cancer, as well as emphysema, chronic bronchitis, 
various heart problems, tooth decay, gum disease 
(gingivitis). Even these harmful chemicals are not only 
the threat to the life of those who are smoking but also 
very dangerous to the progeny of the smokers because 
these chemicals bind to human DNA and cause mutations 
that complicates over time. In fact, tobacco is one of the 
leading preventable causes of death in the world, 
according to a report by the center of disease control. 
Nicotine is present in all the tobacco products and is 
highly addictive. As the bioavailability of nicotine is very 
high, within very short period of time nicotine reaches to 
brain. It stimulates the brain for the production 
adrenaline which in turn causes a buzz of pleasure and 
energy. With this wish of pleasure and energy again, 
tobacco user become dependent and develop a high 
tolerance to tobacco. Tobacco also causes may 
withdrawal effects like increased appetite and weight 
gain, constipation, headache, anxiety, irritability, stress, 
nausea and insomnia. So in present scenario smoking 
cessation is of great concern in reference to public health. 
In smoking cessation e-cigarettes are now very popular 2. 
The first E-cigarette was invented in 2003 by a Chinese 
pharmacist Hon Lik as a means to quit smoking. Presently 
electronic nicotine cigarettes (ENC) are available in 
hundreds of different brands and models, along with 
many of different liquid formulations sold in cartridges or 
in small refill bottles. In January 2014, Zhu et al. 
conducted a study in a US and observed 466 brands of 
devices and 7,764 unique flavors advertised on the 
internet 3. Flavors include tobacco and many others 
claiming as having the characteristics of fruits, sweets, 
drinks (coffee, alcoholic beverages 4,5. Different brands 
also vary in amount of nicotine delivered per puff i.e. 0µg 
to 35µg and the accuracy of labeling of nicotine content 
6,7. The market of ENC has shown a tremendous growth 
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over the last few years. Users of e-cigarettes are now 
these days increasing at very high rate worldwide, with 
the result retail sales are expected to reach US$ 5 billion 
by the end of 2016.  
STRUCTURAL COMPONENTS  
Electronic cigarettes are novel type of nicotine delivery 
system which helps the user to inhale the vaporized 
nicotine. These electronic cigarettes are also known as e-
cigarettes, vapes. These E-cigarettes are very similar in 
size and structure of normal conventional tobacco 
cigarettes. There are basically four main parts of E-
cigarettes. The first is the mouth piece, this part of the E-
cigarettes enable the user to inhale vaporized nicotine by 
holding it in between the lips. The second is the 
replaceable cartridge that contains the liquid mixture of 
nicotine, propylene glycol or vegetable glycerin and 
flavoring agents. Third part of the device is responsible 
for heating the liquid mixture and turns it into vapors, is 
called as atomizer. The fourth and the last part of the E-
cigarettes is battery which supplies power to the heating 
element for the vaporization of liquid mixture. 
 
 
 
 
 
 
 
 
Figure 1: Different components of Electronic Nicotine Cigarette (ENC) 
 
WORKING MECHANISM 
Cartridge filled with liquid mixture of nicotine, propylene 
glycol, vegetable glycerol, water, ethanol, flavoring agents 
is assembled with the all other parts of ENC. Then 
activation of EN-cigarette can be done by pressing the 
button or by applying the suction as desired by the user 8-
10. By the activation heating of liquid mixture starts which 
leads to the vaporization of components of liquid mixture 
and ultimately inhaled by the user. 
ROLE OF E-CIGARETTES IN SMOKING 
CESSATION 
In smoking cessation treatment various medications such 
as nicotine replacement therapies are in use and effective 
also, but long-term quit rates are around one in eight 
smokers which is very low 11,12. The key of reducing the 
harmful effects of tobacco is eliminating the inhalation of 
the combustion products generated when tobacco is 
burned at high temperatures 
The most common method of consuming tobacco is by 
burning which is also called smoking. Burning of tobacco 
in the form conventional tobacco cigarettes releases 
many deadly chemicals like tar which get inhaled while 
smoking [13. Use of ENCs eliminates many of these 
chemicals, because burning of tobacco is replaced with 
vaporization of nicotine. Hence ENC are the less harmful.  
E-cigarettes also reduces the risk of others inhaling 
secondhand smoke. Because e-cigs only emit vapor when 
they are exhaled, the amount of exposure other people 
receive is significantly less than when a traditional 
cigarette is smoked. Smokers use ENC for different 
reasons but the most widely reported ones are for 
smoking cessation, to cut down the number of cigarettes 
smoked per day, and to use a product that is perceived as 
being ‘healthier’ than conventional cigarettes 14,15.  
According to studies in three different countries related 
to ENCs from 2010 - 2013 shown that ENCs were capable 
of reducing tobacco dependence and withdrawal 
symptoms 16-21. Some other small non-randomised 
studies also revealed that conventional cigarettes quit 
rates ranging from 22% to 49% using EC 22,23. Similar 
evidence from many randomized controlled studies 
reflects that nicotine ENCs help smokers quit long term, 
compared with placebo ENCs 24 and also concluded the 
ability of ENCs are similar to that of nicotine patches 25 in 
smoking cessation.  
DILEMMA ABOUT ENC 
Pros of using ENC  
Regarding the exposure to toxic chemicals, the use of ENC 
is considered as much safer than that of the conventional 
cigarettes. Primarily, an ENC vapor does not contain tar, 
carbon monoxide, nor most of the injurious chemicals 
found in cigarette smoke 26-28. Authorized body of 
England Public Heath has reported in its latest report that 
ENCs are 95% safer than normal tobacco cigarettes. On 
the other hand some of studies have identified the 
presence of toxic substance in ENCs and these findings 
have attracted wide media coverage 29. But the presence 
of the toxic chemicals in ENC is 9 to 1,000 times lower 
which is slightly more harmful than pharmaceutical grade 
nicotine products used in NRT 30. A study have also 
shown that patient using ENC have improved lung 
functions and also reported many other health benefits as 
compared to those who continue use normal cigarettes. 
These health benefits in patients using ENCs are due to 
less smoke inhaled 31. 
Cons of using ENC 
The FDA found low levels of nicotine in 17 (94%) of 18 of 
the cartridges tested through a laboratory analysis 
conducted in US 32. As nicotine is present in e-cigarettes 
and cigarettes, these are highly addictive means of 
inhaling nicotine.  In addition to nicotine, although ENC 
do not produce tobacco smoke, they contain other 
potentially toxic chemicals, including formaldehyde and 
acetaldehyde 33. Furthermore, the long- term health 
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consequences of e-cigarette use till remain unpredictable. 
According the FDA conducted analytical studies ENCs 
were positive for carcinogenic and toxic chemicals such 
as diethylene glycol, formaldehyde and acetaldehyde.  
The FDA Center for Drug Evaluation and Research has not 
deemed E-cigarettes to be safe and effective for helping 
smokers to quit 34. In 2013, the ALA reports that 76.8% of 
consumers use e-cigarettes and were found to also smoke 
conventional cigarettes simultaneously, instead of 
quitting 35. A study published by the American Heart 
Association (AHA) in Mayo Clinic Proceedings, stated that 
clinicians not recommend e-cigarettes as initial cessation 
aids. But, if primary smoking cessation method fails 
consumer can choose ENCs as an aid for quitting. No level 
of tobacco exposure is safe. Smoking cessation should 
always be recommended.  
Recent in vitro studies by Barrington-Trimis et al 
published in a Journal of the American Medical 
Association suggest that the cytotoxic effects of e-liquids 
were largely because of flavoring agents 36. The ALA 
study found “ the number of middle and high school 
students who used e-cigarettes but never smoked a 
cigarette has increased to an alarming level” The study 
also found that these youths were almost 2 times more 
likely to intend to begin smoking regular cigarettes 
compared with youths who had never used e-
cigarettes.9has voiced concerns about e-cigarettes being a 
“gateway” to conventional cigarettes5 and has referred to 
a recent study that evaluated middle school and high 
school students. 
A recent report in the New England Journal of Medicine 
suggests that e-cigarettes stimulate the teen smokers to 
use more dangerous drugs and act as “gateway for the 
drugs,” like cocaine, marijuana, tobacco, alcohol. ENC 
serve as an alternative to smoking, a way for users to kick 
their habit of smoking. Despite claims by manufacturers 
of their safety the Food and Drug Administration (FDA) 
has banned the imports of ENC. The Canadian authorities 
also clamp down the import of these electronic devices in 
their country.   
CONCLUSION  
On the basis of no combustion technique in the use of 
ENC, these devices are comparatively much less harmful 
than conventional cigarettes. Because the use of 
vaporization process in ENC avoid the threat from many 
toxic chemicals. Indeed existing evidences also indicates 
that many harmful chemicals are also released in the ENC 
vapors. This advanced method of inhaling nicotine is also 
addictive to the same level as that of conventional 
cigarettes. So it is advised to the health care professional 
not to recommend ENC as primary cessation tool. But 
simultaneously the use of ENCs is recommended to the 
patients only as substitute of conventional cigarettes or 
to prevent frequent smoking relapse. 
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